2jgz › Citations

Cyclin B and cyclin A confer different substrate recognition properties on CDK2.

Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, Johnson LN
Cell Cycle 6 1350-9 (2007)
Cited: 67 times
EuropePMC logo PMID: 17495531

Abstract

The transitions of the cell cycle are regulated by the cyclin dependent protein kinases (CDKs). The cyclins activate their respective CDKs and confer substrate recognition properties. We report the structure of phospho-CDK2/cyclin B and show that cyclin B confers M phase-like properties on CDK2, the kinase that is usually associated with S phase. Cyclin B produces an almost identical activated conformation of CDK2 as that produced by cyclin A. There are differences between cyclin A and cyclin B at the recruitment site, which in cyclin A is used to recruit substrates containing an RXL motif. Because of sequence differences this site in cyclin B binds RXL motifs more weakly than in cyclin A. Despite similarity in kinase structures, phospho-CDK2/cyclin B phosphorylates substrates, such as nuclear lamin and a model peptide derived from p107, at sequences SPXX that differ from the canonical CDK2/cyclin A substrate recognition motif, SPXK. CDK2/cyclin B phosphorylation at these non-canonical sites is not dependent on the presence of a RXL recruitment motif. The p107 peptide contains two SP motifs each followed by a non-canonical sequence of which only one site (Ser640) is phosphorylated by pCDK2/cyclin A while two sites are phosphorylated by pCDK2/cyclin B. The second site is too close to the RXL motif to allow the cyclin A recruitment site to be effective, as previous work has shown that there must be at least 16 residues between the catalytic site serine and the RXL motif. Thus the cyclins A and B in addition to their role in promoting the activatory conformational switch in CDK2, also provide differential substrate specificity.

Reviews - 2jgz mentioned but not cited (2)

  1. Structural insights into the functional diversity of the CDK-cyclin family. Wood DJ, Endicott JA. Open Biol 8 180112 (2018)
  2. Ser or Leu: structural snapshots of mistranslation in Candida albicans. Sárkány Z, Silva A, Pereira PJ, Macedo-Ribeiro S. Front Mol Biosci 1 27 (2014)

Articles - 2jgz mentioned but not cited (21)

  1. Proteome-wide covalent ligand discovery in native biological systems. Backus KM, Correia BE, Lum KM, Forli S, Horning BD, González-Páez GE, Chatterjee S, Lanning BR, Teijaro JR, Olson AJ, Wolan DW, Cravatt BF. Nature 534 570-574 (2016)
  2. Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling. Alexander J, Lim D, Joughin BA, Hegemann B, Hutchins JR, Ehrenberger T, Ivins F, Sessa F, Hudecz O, Nigg EA, Fry AM, Musacchio A, Stukenberg PT, Mechtler K, Peters JM, Smerdon SJ, Yaffe MB. Sci Signal 4 ra42 (2011)
  3. Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Wang Y, Fisher JC, Mathew R, Ou L, Otieno S, Sublet J, Xiao L, Chen J, Roussel MF, Kriwacki RW. Nat Chem Biol 7 214-221 (2011)
  4. The structure of CDK4/cyclin D3 has implications for models of CDK activation. Takaki T, Echalier A, Brown NR, Hunt T, Endicott JA, Noble ME. Proc Natl Acad Sci U S A 106 4171-4176 (2009)
  5. Multiple mechanisms determine the order of APC/C substrate degradation in mitosis. Lu D, Hsiao JY, Davey NE, Van Voorhis VA, Foster SA, Tang C, Morgan DO. J Cell Biol 207 23-39 (2014)
  6. Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activities. Shao H, Shi S, Huang S, Hole AJ, Abbas AY, Baumli S, Liu X, Lam F, Foley DW, Fischer PM, Noble M, Endicott JA, Pepper C, Wang S. J Med Chem 56 640-659 (2013)
  7. Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells. Liu Z, Wang F, Zhou ZW, Xia HC, Wang XY, Yang YX, He ZX, Sun T, Zhou SF. Am J Transl Res 9 845-873 (2017)
  8. Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding. Pascreau G, Eckerdt F, Churchill ME, Maller JL. Proc Natl Acad Sci U S A 107 2932-2937 (2010)
  9. Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97. Steingruber M, Keller L, Socher E, Ferre S, Hesse AM, Couté Y, Hahn F, Büscher N, Plachter B, Sticht H, Marschall M. J Biol Chem 294 6188-6203 (2019)
  10. A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins. Cheng TM, Goehring L, Jeffery L, Lu YE, Hayles J, Novák B, Bates PA. PLoS Comput Biol 8 e1002738 (2012)
  11. Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas. Liu C, Li H, Wang K, Zhuang J, Chu F, Gao C, Liu L, Feng F, Zhou C, Zhang W, Sun C. Front Oncol 9 368 (2019)
  12. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A, Stamminger T, Amin B, Couté Y, Hutterer C, Marschall M. Viruses 8 E219 (2016)
  13. The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain. Steingruber M, Socher E, Hutterer C, Webel R, Bergbrede T, Lenac T, Sticht H, Marschall M. Viruses 7 4582-4601 (2015)
  14. A novel binding pocket of cyclin-dependent kinase 2. Chen H, Van Duyne R, Zhang N, Kashanchi F, Zeng C. Proteins 74 122-132 (2009)
  15. Multiscale Monte Carlo Sampling of Protein Sidechains: Application to Binding Pocket Flexibility. Nilmeier J, Jacobson M. J Chem Theory Comput 4 835-846 (2008)
  16. Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo. Zhang Y, Lv P, Ma J, Chen N, Guo H, Chen Y, Gan X, Wang R, Liu X, Fan S, Cong B, Kang W. Acta Pharm Sin B 12 890-906 (2022)
  17. Design criteria for minimalist mimics of protein-protein interface segments. Taechalertpaisarn J, Lyu RL, Arancillo M, Lin CM, Jiang Z, Perez LM, Ioerger TR, Burgess K. Org Biomol Chem 17 908-915 (2019)
  18. Emerging approaches to CDK inhibitor development, a structural perspective. Hope I, Endicott JA, Watt JE. RSC Chem Biol 4 146-164 (2023)
  19. Protein surface characterization using an invariant descriptor. Abu Deeb Z, Adjeroh DA, Jiang BH. Int J Biomed Imaging 2011 918978 (2011)
  20. Time-series transcriptomic screening of factors contributing to the cross-tolerance to UV radiation and anhydrobiosis in tardigrades. Yoshida Y, Satoh T, Ota C, Tanaka S, Horikawa DD, Tomita M, Kato K, Arakawa K. BMC Genomics 23 405 (2022)
  21. CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation. Quandt E, Masip N, Hernández-Ortega S, Sánchez-Botet A, Gasa L, Fernández-Elorduy A, Plutta S, Martínez-Láinez JM, Bru S, Munoz-Torres PM, Floor M, Villà-Freixa J, Morris MC, Vidal A, Villanueva A, Clotet J, Ribeiro MPC. Mol Oncol 17 1228-1245 (2023)


Reviews citing this publication (3)

  1. Survey of the year 2007 commercial optical biosensor literature. Rich RL, Myszka DG. J Mol Recognit 21 355-400 (2008)
  2. Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2. Li Y, Zhang J, Gao W, Zhang L, Pan Y, Zhang S, Wang Y. Int J Mol Sci 16 9314-9340 (2015)
  3. Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective. Dom M, Vanden Berghe W, Van Ostade X. RSC Med Chem 11 30-50 (2020)

Articles citing this publication (41)

  1. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. Baumli S, Lolli G, Lowe ED, Troiani S, Rusconi L, Bullock AN, Debreczeni JE, Knapp S, Johnson LN. EMBO J 27 1907-1918 (2008)
  2. CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. Brown NR, Korolchuk S, Martin MP, Stanley WA, Moukhametzianov R, Noble MEM, Endicott JA. Nat Commun 6 6769 (2015)
  3. Proteins feel more than they see: fine-tuning of binding affinity by properties of the non-interacting surface. Kastritis PL, Rodrigues JP, Folkers GE, Boelens R, Bonvin AM. J Mol Biol 426 2632-2652 (2014)
  4. Distinct sequence elements of cyclin B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis. Bentley AM, Normand G, Hoyt J, King RW. Mol Biol Cell 18 4847-4858 (2007)
  5. A Dual Inhibitory Mechanism Sufficient to Maintain Cell-Cycle-Restricted CENP-A Assembly. Stankovic A, Guo LY, Mata JF, Bodor DL, Cao XJ, Bailey AO, Shabanowitz J, Hunt DF, Garcia BA, Black BE, Jansen LET. Mol Cell 65 231-246 (2017)
  6. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. Yan H, Li Z, Shen Q, Wang Q, Tian J, Jiang Q, Gao L. Pathol Res Pract 213 316-321 (2017)
  7. Toward a molecular structure of the eukaryotic kinetochore. Welburn JP, Cheeseman IM. Dev Cell 15 645-655 (2008)
  8. C. elegans mitotic cyclins have distinct as well as overlapping functions in chromosome segregation. van der Voet M, Lorson MA, Srinivasan DG, Bennett KL, van den Heuvel S. Cell Cycle 8 4091-4102 (2009)
  9. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Li C, Andrake M, Dunbrack R, Enders GH. Mol Cell Biol 30 116-130 (2010)
  10. Cyclin-Specific Docking Mechanisms Reveal the Complexity of M-CDK Function in the Cell Cycle. Örd M, Venta R, Möll K, Valk E, Loog M. Mol Cell 75 76-89.e3 (2019)
  11. Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Bogdanow B, Weisbach H, von Einem J, Straschewski S, Voigt S, Winkler M, Hagemeier C, Wiebusch L. Proc Natl Acad Sci U S A 110 17510-17515 (2013)
  12. Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture. Eswaran J, Bernad A, Ligos JM, Guinea B, Debreczeni JE, Sobott F, Parker SA, Najmanovich R, Turk BE, Knapp S. Structure 16 115-124 (2008)
  13. Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint. Jackman M, Marcozzi C, Barbiero M, Pardo M, Yu L, Tyson AL, Choudhary JS, Pines J. J Cell Biol 219 e201907082 (2020)
  14. The cryoelectron microscopy structure of the human CDK-activating kinase. Greber BJ, Perez-Bertoldi JM, Lim K, Iavarone AT, Toso DB, Nogales E. Proc Natl Acad Sci U S A 117 22849-22857 (2020)
  15. Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy. Mohammad T, Batra S, Dahiya R, Baig MH, Rather IA, Dong JJ, Hassan I. Molecules 24 E4589 (2019)
  16. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation. Ruiz EJ, Hunt T, Nebreda AR. Mol Cell 32 210-220 (2008)
  17. PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, Vetter B, Lenac-Rovis T, Jonjic S, Neitzel H, Hagemeier C, Wiebusch L. PLoS Pathog 10 e1004514 (2014)
  18. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis. Xiao JF, Sun QY, Ding LW, Chien W, Liu XY, Mayakonda A, Jiang YY, Loh XY, Ran XB, Doan NB, Castor B, Chia D, Said JW, Tan KT, Yang H, Fu XY, Lin DC, Koeffler HP. J Pathol 246 89-102 (2018)
  19. Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding. Dixon-Clarke SE, Elkins JM, Cheng SW, Morin GB, Bullock AN. Sci Rep 5 17122 (2015)
  20. Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1 kinase. Shehata SN, Hunter RW, Ohta E, Peggie MW, Lou HJ, Sicheri F, Zeqiraj E, Turk BE, Sakamoto K. Cell Signal 24 2085-2094 (2012)
  21. Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. Örd M, Puss KK, Kivi R, Möll K, Ojala T, Borovko I, Faustova I, Venta R, Valk E, Kõivomägi M, Loog M. Cell Rep 31 107757 (2020)
  22. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design. Kontopidis G, Andrews MJ, McInnes C, Plater A, Innes L, Renachowski S, Cowan A, Fischer PM. ChemMedChem 4 1120-1128 (2009)
  23. Candida albicans cyclin Clb4 carries S-phase cyclin activity. Ofir A, Kornitzer D. Eukaryot Cell 9 1311-1319 (2010)
  24. Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives. Al Sheikh Ali A, Khan D, Naqvi A, Al-Blewi FF, Rezki N, Aouad MR, Hagar M. ACS Omega 6 301-316 (2021)
  25. Lactate regulates cell cycle by remodelling the anaphase promoting complex. Liu W, Wang Y, Bozi LHM, Fischer PD, Jedrychowski MP, Xiao H, Wu T, Darabedian N, He X, Mills EL, Burger N, Shin S, Reddy A, Sprenger HG, Tran N, Winther S, Hinshaw SM, Shen J, Seo HS, Song K, Xu AZ, Sebastian L, Zhao JJ, Dhe-Paganon S, Che J, Gygi SP, Arthanari H, Chouchani ET. Nature 616 790-797 (2023)
  26. Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells. Kurzawa L, Pellerano M, Coppolani JB, Morris MC. PLoS One 6 e26555 (2011)
  27. An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases. Chen D, Ning Z, Chen H, Lu C, Liu X, Xia T, Qi H, Wang W, Ling T, Guo X, Tekcham DS, Liu X, Liu J, Wang A, Yan Q, Liu JW, Tan G, Piao HL. Oncogene 39 587-602 (2020)
  28. Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer. Dong Z, Zhao L, Lu S, Xiong J, Geng Z. Cancer Biother Radiopharm 31 353-359 (2016)
  29. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen `NNK´ Induced Carcinogenesis: A System Biology Approach. Anukriti, Dhasmana A, Uniyal S, Somvanshi P, Bhardwaj U, Gupta M, Haque S, Lohani M, Kumar D, Ruokolainen J, Kesari KK. Genes (Basel) 10 E564 (2019)
  30. 4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC. Lin X, Huang Y, Sun Y, Tan X, Ouyang J, Zhao B, Wang Y, Xing X, Liu J. Cancer Manag Res 12 103-115 (2020)
  31. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis. Mi N, Cao J, Zhang J, Fu W, Huang C, Gao L, Yue P, Bai B, Lin Y, Meng W, Li X. Oncol Lett 20 1695-1708 (2020)
  32. Biallelic variant in cyclin B3 is associated with failure of maternal meiosis II and recurrent digynic triploidy. Fatemi N, Salehi N, Pignata L, Palumbo P, Cubellis MV, Ramazanali F, Ray P, Varkiani M, Reyhani-Sabet F, Biglari A, Sparago A, Acurzio B, Palumbo O, Carella M, Riccio A, Totonchi M. J Med Genet 58 783-788 (2021)
  33. Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifs. Ji X, Huang Q, Yu L, Nussinov R, Ma B. Int J Mol Sci 15 13275-13298 (2014)
  34. Association of RGS20 expression with the progression and prognosis of renal cell carcinoma. Jiang L, Shen J, Zhang N, He Y, Wan Z. Oncol Lett 22 643 (2021)
  35. Canonical and Alternative Pathways in Cyclin-Dependent Kinase 1/Cyclin B Inactivation upon M-Phase Exit in Xenopus laevis Cell-Free Extracts. Kubiak JZ, El Dika M. Enzyme Res 2011 523420 (2011)
  36. A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells. Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y. Bioorg Med Chem Lett 18 4633-4637 (2008)
  37. Bipartite binding of the N terminus of Skp2 to cyclin A. Kelso S, Orlicky S, Beenstock J, Ceccarelli DF, Kurinov I, Gish G, Sicheri F. Structure 29 975-988.e5 (2021)
  38. Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers. Venkadakrishnan VB, Yamada Y, Weng K, Idahor O, Beltran H. Mol Cancer Res 21 497-510 (2023)
  39. Anti-Proliferative and Cytoprotective Activity of Aryl Carbamate and Aryl Urea Derivatives with Alkyl Groups and Chlorine as Substituents. Oshchepkov M, Kovalenko L, Kalistratova A, Ivanova M, Sherstyanykh G, Dudina P, Antonov A, Cherkasova A, Akimov M. Molecules 27 3616 (2022)
  40. Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. Li X, Li J, Zhao L, Wang Z, Zhang P, Xu Y, Wu G. Comput Math Methods Med 2022 2465598 (2022)
  41. Epigenetic toxicity and cytotoxicity of perfluorooctanoic acid and its effects on gene expression in embryonic mouse hypothalamus cells. Kim H, Hong MW, Bae YH, Lee SJ. Arh Hig Rada Toksikol 72 182-190 (2021)


Quick links